文献速递新生儿

11个国际新生儿网络22至23周早产儿结局分析

Outcomes of Preterm Infants Born at 22 to 23 Weeks' Gestation in 11 International Neonatal Networks.
PubMed 文献 · JAMA Pediatr · 2025-01-01

该国际登记队列研究纳入2015至2021年11个新生儿网络收治的5019例22至23周早产儿,评估存活率及主要并发症的网络间差异。结果显示不同网络在产前激素、剖宫产、存活率及严重并发症方面存在显著差异,提示需针对变异原因开展研究。

要点

  • 22至23周早产儿存活率及主要并发症在11个新生儿网络间存在显著差异。
  • 各网络产前激素使用率、剖宫产率及院外出生比例差异明显。
  • 标准化发病比显示部分网络存活与并发症表现优于参考人群。

核心结论

  • 22至23周早产儿结局在11个新生儿网络间存在实质性国际差异。
  • 差异可能源于系统、护理实践、态度和文化不同,识别变异有助于聚焦因果决定因素研究。

研究设计与样本

  • 国际登记基于队列研究,纳入2015年1月1日至2021年12月31日出生、无主要先天畸形且收入新生儿重症监护的22至23周早产儿。
  • 共纳入5019例,其中22周846例、23周4173例,来自12个国家或地区的11个新生儿联盟。

主要发现

  • 22周和23周存活至出院 adjusted 概率的95%CI分别为9%-64%和16%-80%(P < .001)。
  • 22周和23周严重PVH或PVL发生率分别为24%-65%和18%-56%(P < .001)。
  • 22周和23周无严重PVH或PVL存活率分别为7%-53%和9%-69%(P < .001)。
  • 存活者中治疗ROP发生率22周为32%-57%(P = .008),23周为16%-48%(P < .001)。
  • 23周存活者中BPD发生率为64%-88%(P < .001),NEC发生率为6%-28%(P < .001)。

关键数值与推荐

  • 各网络22周和23周产前激素使用范围分别为18%-83%和57%-98%。
  • 各网络22周和23周剖宫产率范围分别为0%-42%和5%-73%。
  • 各网络22周和23周院外出生比例范围分别为0%-26%和0%-22%。

临床怎么用

  • 可为22至23周早产儿父母咨询提供多国网络结局差异信息。
  • 识别网络间变异有助于质量改进和基准比较。
  • 临床实践需关注产前激素、分娩方式及新生儿护理的系统性差异。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Postnatal intensive care for preterm infants born at 22 to 23 weeks' gestation is increasing, although survival rates remain low. Information on outcomes for multiple countries or regions can be important for research, benchmarking, quality improvement, and parental counseling. OBJECTIVE: To evaluate survival and major morbidities and their between-network variations in infants born at 22 to 23 weeks' gestation in 11 neonatal networks participating in the International Network for Evaluation of Outcomes (iNeo) in neonates in 12 countries or regions. DESIGN, SETTING, AND PARTICIPANTS: International registry-based cohort study of infants born at 22 to 23 weeks' gestation from January 1, 2015, through December 31, 2021, without major congenital anomalies who were admitted for neonatal intensive care in 11 national or regional neonatal consortia. Data analysis was performed from December 2, 2023, to June 15, 2025. EXPOSURES: Neonatal consortium and gestational age at birth. MAIN OUTCOMES AND MEASURES: Survival to neonatal intensive care unit discharge, major neonatal morbidities, and survival without any major morbidities. RESULTS: A total of 5019 neonates were included (1084 of 4636 neonates [23%] with a maternal age >35 years; 2641 of 5017 neonates [53%] male); among them, 846 neonates were born at 22 weeks' gestation and 4173 were born at 23 weeks' gestation. Variations between contributing networks for perinatal management at 22 and 23 weeks' gestation, respectively, include any antenatal steroids (ranges of 18%-83% and 57%-98%), cesarean birth (0%-42% and 5%-73%), and outborn (0%-26% and 0%-22%). Significant variations between contributing networks for adjusted probabilities of outcomes at 22 and 23 weeks' gestation, respectively, include survival to discharge (95% CIs of 9%-64% and 16%-80%; P < .001), grade 3 or 4 periventricular hemorrhage (PVH) or periventricular leukomalacia (PVL) (severe PVH or PVL: 24%-65% and 18%-56%; P < .001), survival without severe PVH or PVL (7%-53% and 9%-69%; P < .001), treated retinopathy of prematurity among survivors (32%-57% [P = .008] and 16%-48% [P < .001]), bronchopulmonary dysplasia among survivors (for 23 weeks only: 64%-88%; P < .001), and necrotizing enterocolitis (for 23 weeks only: 6%-28%; P < .001). Standardized incidence ratios showed significant differences in survival and major morbidities in some networks compared with a reference population from all other networks. CONCLUSIONS: Substantial international variations were identified in outcomes for infants born at 22 to 23 weeks' gestation who were admitted to 11 neonatal networks in the 12 countries or regions. The variations can be due to differences in systems, care practices, attitudes, and culture; however, identification of variation can help focus efforts toward research aimed at understanding the causal determinants of variation.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Isayama T, Norman M, Kusuda S, et al. Outcomes of Preterm Infants Born at 22 to 23 Weeks' Gestation in 11 International Neonatal Networks. JAMA Pediatr. 2025. PMID: 40853670. doi:10.1001/jamapediatrics.2025.2958

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。